abstract |
This invention relates to novel 3-phenylquinazolin-4-one compounds, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering an inhibitor of phosphoinositide 3-kinase (PI3K). |